fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Tepmetko is approved in Japan for the treatment of patients with unresectable, advanced or recurrent non-small cell lung cancer with MET exon 14 (METex14) skipping alterations.- Merck KGaA

Written by | 27 Mar 2020

Merck KGaA announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Tepmetko (tepotinib) for the treatment of patients with unresectable, advanced or recurrent non-small… read more.

FDA accepts for filing NDA for JZP 258 for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years of age and older with narcolepsy.-Jazz Pharma

Written by | 27 Mar 2020

Jazz Pharmaceuticals plc announced that the FDA accepted for filing with Priority Review the company’s New Drug Application (NDA) seeking marketing approval for JZP 258, an investigational medicine… read more.

NanoFlu, seasonal influenza vaccine , achieves all primary endpoints in phase III clinical trial.-Novavax Inc.

Written by | 27 Mar 2020

Novavax, Inc. announced positive top-line results of its pivotal Phase III clinical trial of NanoFlu , its recombinant quadrivalent seasonal influenza vaccine candidate with its proprietary Matrix-M adjuvant,… read more.

Phase IV trial data with Rayaldee shows efficacy in chronic kidney disease.- OPKO Health

Written by | 27 Mar 2020

OPKO Health reported interim results from an ongoing Phase IV clinical trial comparing Rayaldee with three common treatment regimens for secondary hyperparathyroidism (SHPT) in adult patients with stage… read more.

EU awards CE mark approval to EBX 041 SARS CoV2 diagnostic test for Coronavirus.- Eurobio Scientific

Written by | 27 Mar 2020

Eurobio Scientific announced CE mark approval for its EBX 041 SARS CoV2 proprietary test, developed specifically for the clinical diagnosis of COVID-19. The EBX 041 SARS CoV2 proprietary… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.